Evaluating the effects of Esmolol on cardiac function in patients with Septic cardiomyopathy by Speck-tracking echocardiography-a randomized controlled trial.

BMC Anesthesiol · 2023 · PMC9912519 · PMID 36765286

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

After Esmolol was applied for 3 consecutive days, the heart rate of patients in Group E was maintained at the target heart rate, while the norepinephrine dosage presented a decreasing trend.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.